Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...
Novavax (NVAX) stock fell after a clarification on an analyst report led to a sharp rally in the company stock in the ...
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
Shares of Novavax Inc. NVAX shed 5.62% to $13.61 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.22% to ...
Novavax uses a protein-based vaccine strategy, which means people getting the vaccine receive a protein made by the virus ...
TORONTO — The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus ...
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say.
On Thursday, Novavax Inc (NVAX) stock saw a decline, ending the day at $14.42 which represents a decrease of $-0.26 or -1.77% from the prior close of $14.68. The stock opened at $14.07 and touched a ...
The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing ...
Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.